225 related articles for article (PubMed ID: 11179369)
1. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin.
Eisenhauer PB; Chaturvedi P; Fine RE; Ritchie AJ; Pober JS; Cleary TG; Newburg DS
Infect Immun; 2001 Mar; 69(3):1889-94. PubMed ID: 11179369
[TBL] [Abstract][Full Text] [Related]
2. Endothelial heterogeneity in Shiga toxin receptors and responses.
Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
[TBL] [Abstract][Full Text] [Related]
3. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.
Takahashi K; Funata N; Ikuta F; Sato S
J Neuroinflammation; 2008 Mar; 5():11. PubMed ID: 18355415
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression.
Stricklett PK; Hughes AK; Ergonul Z; Kohan DE
J Infect Dis; 2002 Oct; 186(7):976-82. PubMed ID: 12232838
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
[TBL] [Abstract][Full Text] [Related]
6. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.
Louise CB; Kaye SA; Boyd B; Lingwood CA; Obrig TG
Infect Immun; 1995 Jul; 63(7):2766-9. PubMed ID: 7790096
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis of human brain microvascular endothelial cells by shiga toxin 1.
Ergonul Z; Hughes AK; Kohan DE
J Infect Dis; 2003 Jan; 187(1):154-8. PubMed ID: 12508161
[TBL] [Abstract][Full Text] [Related]
8. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.
Eisenhauer PB; Jacewicz MS; Conn KJ; Koul O; Wells JM; Fine RE; Newburg DS
Microb Pathog; 2004 Apr; 36(4):189-96. PubMed ID: 15001224
[TBL] [Abstract][Full Text] [Related]
10. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.
Louise CB; Obrig TG
Infect Immun; 1991 Nov; 59(11):4173-9. PubMed ID: 1937774
[TBL] [Abstract][Full Text] [Related]
11. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells.
Warnier M; Römer W; Geelen J; Lesieur J; Amessou M; van den Heuvel L; Monnens L; Johannes L
Kidney Int; 2006 Dec; 70(12):2085-91. PubMed ID: 17063173
[TBL] [Abstract][Full Text] [Related]
12. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
[TBL] [Abstract][Full Text] [Related]
13. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome.
Karpman D; Papadopoulou D; Nilsson K; Sjögren AC; Mikaelsson C; Lethagen S
Blood; 2001 May; 97(10):3100-8. PubMed ID: 11342436
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.
Moon DO; Choi SR; Lee CM; Kim GY; Lee HJ; Park YM
J Korean Med Sci; 2005 Aug; 20(4):548-54. PubMed ID: 16100442
[TBL] [Abstract][Full Text] [Related]
16. Induction by sphingomyelinase of shiga toxin receptor and shiga toxin 2 sensitivity in human microvascular endothelial cells.
Obrig TG; Seaner RM; Bentz M; Lingwood CA; Boyd B; Smith A; Narrow W
Infect Immun; 2003 Feb; 71(2):845-9. PubMed ID: 12540565
[TBL] [Abstract][Full Text] [Related]
17. [Effect of cytokines on the expression of Shiga toxin toxicity].
Nakane A; Sasaki S
Nihon Rinsho; 2002 Jun; 60(6):1089-94. PubMed ID: 12078078
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression.
Hughes AK; Ergonul Z; Stricklett PK; Kohan DE
J Am Soc Nephrol; 2002 Sep; 13(9):2239-45. PubMed ID: 12191968
[TBL] [Abstract][Full Text] [Related]
19. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.
van Setten PA; van Hinsbergh VW; van der Velden TJ; van de Kar NC; Vermeer M; Mahan JD; Assmann KJ; van den Heuvel LP; Monnens LA
Kidney Int; 1997 Apr; 51(4):1245-56. PubMed ID: 9083293
[TBL] [Abstract][Full Text] [Related]
20. Escherichia coli Shiga toxin.
Nakao H; Takeda T
J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
